While preventive medical management of cerebrovascular disease, stroke and TIA, secondary to a symptomatic intracranial arterial stenosis (sICAS) is well known and includes dual antiplatelet therapy and high-dose statin, its initial recognition and management can be challenging when the patient presents with an acute stroke syndrome. BP-dependent fluctuating deficit that resolves with supine positioning and fluid administration is a reliable clinical indicator of underlying sICAS. However, BP dependence is often missed in patients presenting with acute stroke syndrome due to time constraints and need for rapid decision making during the acute triage. Penumbra without a core (PWC) on brain CT perfusion (CTP) provides a biomarker that can identify these patients, prevent unnecessary interventions, and allow individualization of treatment. We describe 3 cases that underscore the usefulness of this biomarker.